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Background
Juvenile dermatomyositis (JDM) is characterised by
chronic inflammation in skeletal muscle, skin, and other
target organs. Prognosis has improved in the past 10-20
years, but it is still a disease with high morbidity and
considerable sequelae such as muscle weakness, joint
contractures, calcinosis and lipodystrophy. There is
increasing evidence that single nucleotide polymorph-
isms (SNPs) are associated with chronic inflammatory
diseases. In the present study, we investigated known
SNPs within genes that previously have been associated
with inflammatory myopathies, including JDM and
dermatomyositis.
Aim
The aim of the study was to investigate known poly-
morphisms within the genes encoding Toll-like receptor
(TLR)1-10; nucleotide binding oligomerisation domain
(NOD)1-2; interferon-induced helicase C domain-con-
taining protein 1 (IFIH1); and melanoma differentiation
associated gene 5 (MDA5), as well as single nucleotide
polymorphisms (SNPs) in tumour necrosis factor
(TNF)-alpha and protein tyrosine phosphatase, non-
receptor type 22 (PTPN22) and their association with
the disease course of Juvenile Dermatomyositis (JDM) in
a population-based follow-up study.
Methods
In 53 JDM patients SNPs in the pattern recognition
receptor genes encoding TLR1-10, DDX58 (RIG-I),
IFIH1 (MDA5), NOD1 (CARD4), and NOD2 (CARD15)
were analysed using an in-house multiplex bead-based
assays. The TNF-alpha (rs1800629) and PTPN22
(rs2476601) polymorphisms were genotyped by
pyrosequencing.
Results
The TLR2-rs1898830 SNP was found to be associated
with calcinosis (p=0.006) and lipodystrophy (p=0.0006).
Patients with the G/G genotype had a significantly
higher risk (OR: 60.0, CI: 5.0-719.0) of developing lipo-
dystrophy than patients with the A/A or A/G genotypes.
No other SNPs were significantly associated with JDM
outcome.
Conclusion
The present study suggests an association between
TLR2-rs1898830 and disease outcome in JDM.
Author details
1Dept.of Paediatrics, Holbaek University Hospital, Denmark.
2Institute for
Inflammation Research, Dept. of Rheumatology, Rigshospitalet, University
Hospital of Copenhagen, Denmark.
3Dept. of Biostatistics, University of
Copenhagen, Denmark.
4Laboratory of Molecular Medicine, Dept. of Clinical
Immunology, Rigshospitalet and Allogeneic Hematopoietic Cell
Transplantation Laboratory, University Hospital of Copenhagen, Denmark.
5Dept. of Hematology, Rigshospitalet,Paediatric Clinic II, Rigshospitalet,
University Hospital of Copenhagen, Denmark.
Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-O40
Cite this article as: Mathiesen et al.: Toll-like receptor 2 polymorphism in
juvenile dermatomyositis. Pediatric Rheumatology 2011 9(Suppl 1):O40.
* Correspondence: permat@dadlnet.dk
1Dept.of Paediatrics, Holbaek University Hospital, Denmark
Full list of author information is available at the end of the article
Mathiesen et al. Pediatric Rheumatology 2011, 9(Suppl 1):O40
http://www.ped-rheum.com/content/9/S1/O40
© 2011 Mathiesen et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.